Miravitlles has received speaker or consulting fees from AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, Cipla, CSL Behring, Laboratorios Esteve, Gebro Pharma, Kamada, GlaxoSmithKline, Grifols, Menarini, Mereo Biopharma, Novartis, pH Pharma, Palobiofarma SL, Rovi, TEVA, Spin Therapeutics, Verona Pharma and Zambon, and research grants from Grifols
Q3: If my BMI is already high, should I lose weight before quitting
We recommend burning for minimum 4 hours on your first burn to prevent tunneling
Legislation: complies with the European Parliament's EC regulation N1334/2008 on food flavourings
ban smoking in all indoor public places
Putative health benefits are not anticipated for dual users who consume e-cigarettes and conventional cigarettes in parallel